Suneva® Medical, Inc ., a privately held aesthetics company, is pleased to announce an exclusive strategic partnership to market and distribute Neauvia North America’s Plasma IQ , the first Class 2 FDA cleared plasma energy device throughout North America.
| SAN DIEGO, Sept. 21, 2020 /PRNewswire/ -- Suneva Medical Inc., a privately held aesthetics company, is pleased to announce an exclusive strategic partnership to market and distribute Neauvia North America’s Plasma IQ, the first Class 2 FDA cleared plasma energy device throughout North America.
Plasma IQ is the latest advancement in aesthetics that delivers focused, controlled plasma energy to safely and effectively create microinjuries on the skin, renewing and restoring it. “This is an exciting partnership as Suneva Medical is well positioned to offer a unique technology to a number of providers looking for new aesthetic treatments that are safe and effective,” said Sean Wilson, CEO of Neauvia North America. “We are looking forward to welcoming Plasma IQ to our ever-expanding portfolio of facial regenerative aesthetics products,” said Pat Altavilla, CEO of Suneva Medical. “With the introduction of Plasma IQ, we continue our commitment to providing proven and validated innovations for aesthetic providers and their patients.” About Suneva Medical, Inc. About Neauvia North America Plasma IQ is FDA cleared to be used in the removal and destruction of skin lesions and the coagulation of tissue. The most common side effects are swelling, tenderness, scabbing, and redness. Plasma IQ is Rx only and should only be used by medically licensed and certified practitioners. For full product and safety information, visit plasmaiqtreatment.com/IFU.
SOURCE Suneva Medical, Inc. |
View original content to download multimedia:
